Article
Chemogenetic activation of midline thalamic nuclei fails to ameliorate memory deficits in…
medRxiv · 2022 · Kohli, S.; Andrianova, L.; Margetts-Smith, G.; Brady, E. S.; Craig, M. T.
Key facts
| Title | Chemogenetic activation of midline thalamic nuclei fails to ameliorate memory deficits in two mouse models of Alzheimer’s disease |
|---|---|
| First author | Kohli, S.; Andrianova, L.; Margetts-Smith, G.; Brady, E. S.; Craig, M. T. |
| Journal | medRxiv |
| Published | Mar 14, 2022 |
| DOI | 10.1101/2021.06.30.450500 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1